The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 16, 2025
Filed:
May. 10, 2023
Applicant:
Acasti Pharma U.s., Inc., Wilmington, DE (US);
Inventors:
S. George Kottayil, West Windsor, NJ (US);
Amresh Kumar, Plainsboro, NJ (US);
Prasanna Sunthankar, West Windsor, NJ (US);
Kamalkishore Pati, Old Bridge, NJ (US);
Vimal Kavuru, Holmdel, NJ (US);
Assignee:
Grace Therapeutics U.S., Inc., Princeton, NJ (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4422 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/40 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 31/4422 (2013.01); A61K 9/0029 (2013.01); A61K 9/1075 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01); A61K 47/44 (2013.01);
Abstract
A method of providing an IV nimodipine infusion regimen using a solubilized nimodipine solution suitable for IV administration is disclosed. The IV nimodipine infusion regimen provides a constant infusion rate over the (entire) 24 hour period supplemented with higher infusions of nimodipine at set intervals to duplicate the 24 hour AUC and Cof an oral nimodipine dose.